Non-proprietary names from 'mebhydrolin' to 'meloxicam' - Electronic medicinal guide TALKDRUGS

X.J30-J39.J30   Vasomotor and allergic rhinitis

VII.H10-H13.H10.1   Acute atopic conjunctivitis

X.J30-J39.J30.1   Allergic rhinitis caused by pollen of plants

X.J30-J39.J30.2   Other seasonal allergic rhinitis

X.J40-J47.J45   Asthma

XII.L20-L30.L20.8   Other atopic dermatitis

XII.L20-L30.L29   Itching

XII.L50-L54.L50   Hives

XI.K20-K31.K30   Dyspepsia

XI.K55-K63.K58   Irritable Bowel Syndrome

XI.K55-K63.K59.9   Functional bowel disorder, unspecified

XVIII.R10-R19.R10.1   Pain localized in the upper abdomen

XVIII.R10-R19.R10.4   Other and unspecified abdominal pain

I.B65-B83.B67.8   Echinococcosis of liver, unspecified

I.B65-B83.B67   Echinococcosis

I.B65-B83.B68   Teniosis

I.B65-B83.B75   Trichinosis

I.B65-B83.B76   Ankylostomiasis

I.B65-B83.B77   Ascaridosis

I.B65-B83.B78   Strontyloidosis

I.B65-B83.B79   Trichurosis

I.B65-B83.B80   Enterobiosis

I.B65-B83.B81.4   Intestinal helminthiases of mixed etiology

I.B65-B83.B83.1   Gnathostomy

XXI.Z00-Z13.Z03   Medical surveillance and evaluation in case of suspected disease or pathological condition

II.C50.C50   Malignant neoplasm of breast

II.C51-C58.C54   Malignant neoplasm of uterine body

I.B50-B64.B55   Leishmaniasis

I.A50-A64.A56   Other chlamydial diseases, sexually transmitted diseases

I.A50-A64.A59.0   Urogenital trichomoniasis

I.A50-A64.A60   Anogenital herpetic viral infection [herpes simplex]

I.A65-A69.A69.9   Spirochaetic infection, unspecified

I.A70-A74.A74   Other diseases caused by chlamydia

I.B00-B09.B00   Infections caused by the herpes simplex virus [herpes simplex]

I.B15-B19.B17.1   Acute hepatitis C

I.B15-B19.B16   Acute hepatitis B

I.B15-B19.B15   Acute hepatitis A

I.B15-B19.B17   Other acute viral hepatitis

I.B15-B19.B18.2   Chronic viral hepatitis C

I.B15-B19.B18.1   Chronic viral hepatitis B without delta-agent

I.B15-B19.B19   Viral hepatitis, unspecified

I.B20-B24.B20   Disease caused by the human immunodeficiency virus [HIV], manifested as infectious and parasitic diseases

I.B25-B34.B25   Cytomegalovirus

II.D37-D48.D48.9   Neoplasm of uncertain or unknown nature, unspecified

III.D80-D89.D84.9   Immunodeficiency, unspecified

VI.G00-G09.G03.9   Meningitis, unspecified

VI.G00-G09.G03.0   Non-piogenic meningitis

VI.G35-G37.G35   Multiple sclerosis

X.J00-J06.J06.8   Other acute upper respiratory tract infections of multiple localization

X.J10-J18.J10   Influenza caused by an identified influenza virus

X.J10-J18.J11   Influenza, virus not identified

X.J10-J18.J18   Pneumonia without clarification of the pathogen

X.J40-J47.J42   Chronic bronchitis, unspecified

XI.K20-K31.K26   Duodenal ulcer

XI.K20-K31.K25   Stomach ulcer

XII.L20-L30.L30.9   Dermatitis, unspecified

XII.L20-L30.L20   Atopic dermatitis

XIII.M05-M14.M06.9   Rheumatoid arthritis, unspecified

XIII.M15-M19   Osteoarthritis

XIV.N30-N39.N34   Urethritis and urethral syndrome

XIV.N40-N51.N48.1   Balanoposthitis

XIV.N70-N77.N74.4 *   Inflammatory diseases of female pelvic organs caused by chlamydiae (A56.1 +)

XIV.N70-N77.N76   Other inflammatory diseases of the vagina and vulva

XIX.T20-T32.T30   Thermal and chemical burns, unspecified

XXI.Z20-Z29.Z29.8   Other specified preventive measures

XXI.Z40-Z54.Z51.8   Other specified type of medical care

XXI.Z80-Z99.Z81.1   In a family history, alcohol dependence

V.F10-F19.F10.3   Mental and behavioral disorders caused by alcohol use - withdrawal symptoms

V.F40-F48.F40.2   Specific (isolated) phobias

V.F40-F48.F41.9   Anxiety disorder, unspecified

V.F40-F48.F43.2   Disorder of adaptive reactions

V.F40-F48.F48   Other neurotic disorders

V.F60-F69.F60   Specific personality disorders

V.F60-F69.F60.3   Emotionally unstable personality disorder

VI.G40-G47.G43   Migraine

VI.G40-G47.G47.0   Disturbances of falling asleep and maintaining sleep [insomnia]

XIV.N80-N98.N95.1   Menopause and menopause in women

XVIII.R40-R46.R45.0   Nervousness

XVIII.R40-R46.R45.1   Anxiety and Excitement

XVIII.R40-R46.R45.4   Irritability and anger

II.C50.C50   Malignant neoplasm of breast

II.C51-C58   Malignant neoplasms of female genital organs

II.C51-C58.C54   Malignant neoplasm of uterine body

II.C64-C68.C64   Malignant neoplasm of kidney, except for renal pelvis

XIV.N80-N98.N80   Endometriosis

XIV.N80-N98.N91   Absence of menstruation, meager and rare menstruation

XIV.N80-N98.N93   Other abnormal bleeding from the uterus and vagina

XIV.N80-N98.N94.3   Premenstrual tension syndrome

XIV.N80-N98.N95.1   Menopause and menopause in women

XXI.Z30-Z39.Z30.0   General advice and advice on contraception

XIII.M80-M85.M81.0   Postmenopausal osteoporosis

XIII.M80-M85.M81.1   Osteoporosis after removal of ovaries

XIV.N80-N98.N95.1   Menopause and menopause in women

XIV.N80-N98.N95.3   Conditions associated with artificially induced menopause

XIV.N80-N98.N95.1   Menopause and menopause in women

XV.O30-O48.O48   Mature pregnancy

XV.O60-O75.O62.2   Other types of weakness in labor

XVI.P20-P29.P20.9   Intrauterine hypoxia, unspecified

V.F00-F09.F06.6   Organic emotional labile [asthenic] disorder

V.F10-F19.F10   Mental and behavioral disorders caused by alcohol use

XXI.Z80-Z99.Z81.1   In a family history, alcohol dependence

V.F20-F29.F20.9   Schizophrenia, unspecified

V.F40-F48.F48.0   Neurasthenia

V.F40-F48.F48.9   Neurotic disorder, unspecified

V.F50-F59.F51.1   Drowsiness [hypersomnia] inorganic etiology

V.F70-F79.F79   Mental retardation, unspecified

XVIII.R40-R46.R40.1   Stupor

XVIII.R40-R46.R45.3   Demoralization and apathy

XVIII.R40-R46.R46.4   Retardation and delayed reaction

XVIII.R50-R69.R53   Malaise and fatigue

XIX.T36-T50   Poisoning with medicines, medicines and biological substances

XIX.T51-T65.T65   Toxic effect of other and unspecified substances

XIX.T90-T98.T90.5   Consequences of intracranial injury

XXI.Z70-Z76.Z73.0   Overwork

XXI.Z70-Z76.Z73.6   Limitations of activities caused by a decrease or loss of ability to work

VIII.H80-H83.H81.0   Ménière's disease

VIII.H80-H83.H81.9   Violation of vestibular function, unspecified

XII.L20-L30.L20   Atopic dermatitis

XVIII.R10-R19.R11   Nausea and vomiting

XIX.T66-T78.T78.4   Allergy, unspecified

XX.Y40-Y59   Medicinal products, medicines and biological substances that cause adverse reactions during therapeutic use

V.F40-F48.F45   Somatoform disorders

VI.G40-G47.G45.0   Syndrome of vertebrobasilar arterial system

VI.G40-G47.G46 *   Vascular cerebral syndromes in cerebrovascular diseases (I60-I67 +)

VI.G90-G99.G93.4   Encephalopathy, unspecified

IX.I60-I69.I63   Cerebral infarction

IX.I30-I52.I47.2   Ventricular tachycardia

IX.I30-I52.I49.0   Fibrillation and flutter of the ventricles

IX.I30-I52.I49.3   Premature depolarization of the ventricles

IX.I30-I52.I49.2   Premature depolarization originating from compound

IX.I30-I52.I49.1   Premature depolarization of the atria

IX.I26-I28.I26   Pulmonary embolism

IX.I70-I79.I74   Embolism and thrombosis of the arteries

IX.I80-I89.I82   Embolism and thrombosis of other veins

V.F50-F59.F51.0   Insomnia inorganic etiology

VI.G40-G47.G47.0   Disturbances of falling asleep and maintaining sleep [insomnia]

XVIII.R50-R69.R53   Malaise and fatigue

XXI.Z70-Z76.Z73.6   Limitations of activities caused by a decrease or loss of ability to work

VI.G40-G47.G47.9   Sleep disorder, unspecified

VI.G40-G47.G47.0   Disturbances of falling asleep and maintaining sleep [insomnia]

V.F50-F59.F51.0   Insomnia inorganic etiology

XVIII.R40-R46.R45.4   Irritability and anger

XIII.M05-M14.M05   Seropositive rheumatoid arthritis

XIII.M20-M25.M25.5   Pain in the joint

XIII.M15-M19.M15   Polyarthrosis

XIII.M45-M49.M45   Ankylosing spondylitis